| Popis: |
The commercial success of cell-based therapeutics requires suitable margins. This is influenced by the effective management of costs of manufacture and delivery and by the reimbursement available. There are several ways of realizing the value. This chapter is aimed at academic researchers at an early stage in their career as innovators, to introduce new products to the market. The intention is to make newcomers to the innovation process aware of the options available to them and to inspire novel forms of business with added patient benefit. The range of possible models for cell therapies is described. These are characterized, the probable impact on rate of market penetration and margins is examined, and the regulatory hurdles for each model are described. The models are related to current exemplars of each kind, taking account of the clinical interface. Finally, the direction of future research needed in order to utilize the models is described. |
